ClinicalTrials HQ

Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination

Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination

Recruiting · NCT05945524 · Registry updated 2025-04-10
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell ExaminationBlood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingNot applicable2025-04-10NCT05945524

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
University Hospital, Toulouse216

18 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Léon BérardLyonFrance1
CH Annecy GenevoisEpagny Metz- TessyFrance1
CH Saint-EtienneSaint-Priest-en-JarezFrance1
CHRU NancyVandœuvre-lès-NancyFrance2
CHU d'AmiensAmiensFrance1
CHU de BordeauxPessacFrance2
CHU de CaenCaenFrance2
CHU de LilleLilleFrance1
CHU de LyonPierre-BéniteFrance1
CHU de MontpellierMontpellierFrance8
CHU de PoitiersPoitiersFrance1
CHU de RennesRennesFrance1
CHU de ToulouseToulouseFrance5
CHU de ToursToursFrance1
Hôpital NeckerParisFrance1
Hôpital Saint-AntoineParisFrance1
Hôpital Saint-LouisParisFrance3
Polyclinique du Parc DrevonDijonFrance1